Every open market buy and sale of Royalty Pharma plc stock by its officers, directors and 10% owners over the last two years, straight from SEC Form 4 filings. Insiders are only selling over the last 12 months: $0 bought and $111M sold.
Buying and selling by month
open market, last 12 monthsGet an alert when RPRX insiders trade
We read every Form 4 the moment the SEC posts it and tell you when an RPRX officer, director or 10% owner buys on the open market, or sells $250K or more outside a pre-arranged plan, by email or on your phone.
Insider alerts are part of AI Pro. Start with a free account, then add AI Pro when you want the alerts.
Every RPRX insider trade
2 years · newest first| Insider | Type | Price | Held after | Filed | |||
|---|---|---|---|---|---|---|---|
| Nov 17, 2026 | Christopher HiteEVP & Chairman, Partnering | Sale plan | 100,000 | $68.15 | $6.8M | 177,523 | Nov 18Form 4 |
| Nov 17, 2026 | Terrance P. CoyneEVP & CFO | Sale plan | 257,122 | $68.81 | $17.7M | 0 | Nov 18Form 4 |
| Nov 16, 2026 | Marshall UristEVP, Research & Investments | Sale plan | 25,000 | $69.50 | $1.7M | 125,000 | Nov 18Form 4 |
| Oct 5, 2026 | Marshall UristEVP, Research & Investments | Sale plan | 4,126 | $57.10 | $236K | 0 | Oct 5Form 4 |
| Sep 28, 2026 | Marshall UristEVP, Research & Investments | Sale plan | 4,126 | $57.88 | $239K | 4,126 | Sep 30Form 4 |
| Sep 22, 2026 | Christopher HiteEVP & Chairman, Partnering | Sale plan | 100,000 | $58.53 | $5.9M | 270,401 | Sep 24Form 4 |
| Aug 18, 2026 | Christopher HiteEVP & Chairman, Partnering | Sale plan | 100,000 | $59.97 | $6M | 370,401 | Aug 19Form 4 |
| Aug 13, 2026 | Terrance P. CoyneEVP & CFO | Sale plan | 11,002 | $58.68 | $646K | 0 | Aug 17Form 4 |
| Jul 1, 2026 | Marshall UristEVP, Research & Investments | Sale plan | 9,099 | $55.88 | $508K | 0 | Jul 2Form 4 |
| Jun 30, 2026 | Christopher HiteEVP & Chairman, Partnering | Sale plan | 130,000 | $56.50 | $7.3M | 40,000 | Jul 2Form 4 |
| Jun 24, 2026 | Marshall UristEVP, Research & Investments | Sale plan | 9,098 | $55.18 | $502K | 9,099 | Jun 25Form 4 |
| Jun 23, 2026 | Christopher HiteEVP & Chairman, Partnering | Sale plan | 150,000 | $54.40 | $8.2M | 559,399 | Jun 25Form 4 |
| May 26, 2026 | Terrance P. CoyneEVP & CFO | Sale plan | 64,399 | $53.98 | $3.5M | 0 | May 28Form 4 |
| May 20, 2026 | Marshall UristEVP, Research & Investments | Sale plan | 13,684 | $52.75 | $722K | 18,197 | May 21Form 4 |
| May 14, 2026 | Gregory NordenDirector | Sale plan | 3,045 | $53.00 | $161K | 191,803 | May 15Form 4 |
RPRX insider trading FAQ
Are RPRX insiders buying or selling?
Insiders are only selling over the last 12 months. 0 insiders bought $0 of RPRX on the open market in 0 trades, and 5 sold $111M in 39 trades, 100% of that under pre-arranged trading plans.
When did an RPRX insider last buy shares?
There has been no open market insider purchase of RPRX in the last two years.
When did an RPRX insider last sell shares?
Christopher Hite (EVP & Chairman, Partnering) sold 100,000 shares for $6.8M on Nov 17, 2026, under a pre-arranged trading plan.
What is a Form 4?
Company officers, directors and owners of more than 10% of the shares must report trades in the company's stock to the SEC on Form 4 within two business days. This page shows open market buys and sales only. Option exercises, stock awards, gifts and shares withheld for taxes are left out, since they are not decisions to buy or sell.
Why do insider sales matter less than buys?
Insiders sell for many reasons, such as taxes, diversification or a home purchase, and many sales are scheduled months ahead under a 10b5-1 trading plan. They buy on the open market mostly when they expect the shares to rise, which is why buying, and especially several insiders buying together, gets more attention.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Trades come from SEC Form 4 filings as reported by the insiders. Insiders have two business days to report, so a trade can be a few days old when it appears. See all insider cluster buys.
From SEC Form 4 filings · Not investment advice
